News & Events
News & Events
June 1, 2018
Selection of and evidentiary considerations for wearable devices and their measurements for use in regulatory decision making: recommendations from the ePRO Consortium
Byrom B, Watson C, Doll H, Coons SJ, Eremenco S, Ballinger R, McCarthy M, Crescioni M, O’Donohoe P, Howry C. Selection of and evidentiary considerations for wearable devices and their measurements for use in regulatory decision making: recommendations from the ePRO Consortium. Value in Health 2018;21:631-639.
- May 18, 2018
May 17, 2018
New Collaboration Seeks to Speed Huntington’s Disease Drug LicensingThis article originally appeared on HDBuzz and is reprinted here under Creative Commons license. Critical Path Institute launches new initiative to get HD drugs licensed as quickly as possible By Dr Jeff Carroll, Edited by Dr Ed Wild Originally published here on May 09, 2018 Recently the Critical Path Institute announced a new effort – the Huntington’s Disease...
May 14, 2018
Ninth Annual Patient-Reported Outcome Consortium WorkshopApril 25 – 26, 2018 Sheraton Silver Spring Hotel 8777 Georgia Avenue Silver Spring, MD 20910 On April 25-26, 2018 the NINTH ANNUAL PATIENT-REPORTED OUTCOME CONSORTIUM WORKSHOP was held in Silver Spring, Maryland. The overall Workshop objectives were to: Provide an update on FDA’s Clinical Outcome Assessment (COA) Qualification Program and address changes associated with...
May 10, 2018
Training on the Use of Technology to Collect Patient-Reported Outcome Data Electronically in Clinical Trials: Best Practice Recommendations from the ePRO Consortium (May 10, 2018)This webinar provides a recommended framework for training end users, including site staff and study participants, on the use of ePRO technology in clinical trials. The goal of the webinar is to promote consistent and sufficient training prior to initiating data collection. Presenters: Jenny J. Ly, PhD (ERT) and Serge Bodart, MSc (Bracket) PDF version